See the published version of this preprint at Global Health Research and Policy.
This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Learn more about In Review
Research
Xiao-Nong Zhou
National Institute of Parasitic Diseases
Corresponding Author
ORCiD: https://orcid.org/0000-0003-1417-8427
License:
This work is licensed under a CC BY 4.0 License. Read Full License
Background: The Regional Network for Asian Schistosomiasis and other Helminth Zoonoses (RNAS+) launched in 1998, has close partnerships with countries endemic for schistosomiasis and other helminthiasis. RNAS+ has provided an ideal regional platform for policy-making, control, and parasitic diseases research experts in Asian countries. China, one of the initiating countries, has provided significant technical and financial support to the regional network. Although Chinese institutions and other member countries provided great technical and resource support in RNAS+ development, China, and Chinese scientists or institutions’ contributions, have not been evaluated systematically. This study assessed Chinese contributions toward supporting RNAS+ development.
Methods: An assessment research framework was planned to evaluate China’s contribution to RNAS+ in four aspects, including capacity building, funding support, coordination, and cooperation. An anonymous web-based questionnaire was designed to acquire respondents’ basic information, and information on China’s contributions, challenges, and recommendations for RNAS+ development. Each participant scored from 0 to 10 to assess China’s contribution: “0” no contribution, and “10” 100% contribution. Participants who included their e-mail address in the 2017 - 2019 RNAS+ annual workshops were invited to participate the assessment.
Results: Of 71 participants enrolled, 41 responded to the survey, 37 (37/41, 90.24%) of whom were from RNAS+ member countries while the remaining 4 (4/41, 9.76%) were international observers. Most respondents (38/41, 92.68%) are familiar with RNAS+. Respondents reported that China’s contributions were mainly to improve capacity building, and provide funding support, coordination responsibility, and joint application of the cooperation program towards RNAS+ development. The average scores of China’s contributions in the above four fields were 8.92, 8.64, 8.75, and 8.67, respectively, with an overall assessment score of 8.81 (10 maximum score). The challenge of RNAS+ includes the lack of sustainable funding and skills, and most participants indicated their continual need of China’s support.
Conclusions This survey showed that China plays an important role in the development of RNAS+. This network-type organization for disease control and research can yet be regarded as a great potential pattern for China to enhance regional cooperation. These findings can be used to promote future cooperation between China and other RNAS+ member countries.
Keywords
China, RNAS+, assessment, schistosomiasis, Regional cooperation, Contribution
Figure 1
Figure 2
Figure 3
Figure 4
Loading...
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
Peer Review Timeline
CURRENT STATUS: Published
View the published article at Global Health Research and Policy.
Version 3
Posted 20 Jan, 2021
No community comments so far
Editorial decision: Accept
On 12 Jan, 2021
Editor assigned
On 11 Jan, 2021
Submission checks complete
On 11 Jan, 2021
Editor invited
On 11 Jan, 2021
No comments provided
Editorial decision: Minor revision
On 25 Dec, 2020
Review #2 received
Received 21 Dec, 2020
Review #1 received
Received 16 Dec, 2020
Reviewer #2 agreed
On 12 Dec, 2020
Reviewer #1 agreed
On 11 Dec, 2020
Editor assigned
On 08 Dec, 2020
Reviewers invited
Invitations sent on 08 Dec, 2020
Submission checks complete
On 08 Dec, 2020
Editor invited
On 08 Dec, 2020
No comments provided
Editorial decision: Major revision
On 10 Oct, 2020
Review #3 received
Received 10 Oct, 2020
Review #2 received
Received 01 Oct, 2020
Review #1 received
Received 28 Sep, 2020
Reviewer #3 agreed
On 25 Sep, 2020
Reviewer #2 agreed
On 17 Sep, 2020
Reviewer #1 agreed
On 05 Sep, 2020
Reviewers invited
Invitations sent on 01 Sep, 2020
Editor assigned
On 31 Aug, 2020
Submission checks complete
On 30 Aug, 2020
Editor invited
On 30 Aug, 2020
First submitted
On 28 Aug, 2020
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
Subject Areas
Infectious Diseases
Learn more about our company.
See the published version of this preprint at Global Health Research and Policy.
This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Learn more about In Review
Research
Xiao-Nong Zhou
National Institute of Parasitic Diseases
Corresponding Author
ORCiD: https://orcid.org/0000-0003-1417-8427
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
Peer Review Timeline
CURRENT STATUS: Published
View the published article at Global Health Research and Policy.
Version 3
Posted 20 Jan, 2021
No community comments so far
Editorial decision: Accept
On 12 Jan, 2021
Editor assigned
On 11 Jan, 2021
Submission checks complete
On 11 Jan, 2021
Editor invited
On 11 Jan, 2021
No comments provided
Editorial decision: Minor revision
On 25 Dec, 2020
Review #2 received
Received 21 Dec, 2020
Review #1 received
Received 16 Dec, 2020
Reviewer #2 agreed
On 12 Dec, 2020
Reviewer #1 agreed
On 11 Dec, 2020
Editor assigned
On 08 Dec, 2020
Reviewers invited
Invitations sent on 08 Dec, 2020
Submission checks complete
On 08 Dec, 2020
Editor invited
On 08 Dec, 2020
No comments provided
Editorial decision: Major revision
On 10 Oct, 2020
Review #3 received
Received 10 Oct, 2020
Review #2 received
Received 01 Oct, 2020
Review #1 received
Received 28 Sep, 2020
Reviewer #3 agreed
On 25 Sep, 2020
Reviewer #2 agreed
On 17 Sep, 2020
Reviewer #1 agreed
On 05 Sep, 2020
Reviewers invited
Invitations sent on 01 Sep, 2020
Editor assigned
On 31 Aug, 2020
Submission checks complete
On 30 Aug, 2020
Editor invited
On 30 Aug, 2020
First submitted
On 28 Aug, 2020
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
Subject Areas
Infectious Diseases
License:
This work is licensed under a CC BY 4.0 License. Read Full License
View the published article at Global Health Research and Policy.
Background: The Regional Network for Asian Schistosomiasis and other Helminth Zoonoses (RNAS+) launched in 1998, has close partnerships with countries endemic for schistosomiasis and other helminthiasis. RNAS+ has provided an ideal regional platform for policy-making, control, and parasitic diseases research experts in Asian countries. China, one of the initiating countries, has provided significant technical and financial support to the regional network. Although Chinese institutions and other member countries provided great technical and resource support in RNAS+ development, China, and Chinese scientists or institutions’ contributions, have not been evaluated systematically. This study assessed Chinese contributions toward supporting RNAS+ development.
Methods: An assessment research framework was planned to evaluate China’s contribution to RNAS+ in four aspects, including capacity building, funding support, coordination, and cooperation. An anonymous web-based questionnaire was designed to acquire respondents’ basic information, and information on China’s contributions, challenges, and recommendations for RNAS+ development. Each participant scored from 0 to 10 to assess China’s contribution: “0” no contribution, and “10” 100% contribution. Participants who included their e-mail address in the 2017 - 2019 RNAS+ annual workshops were invited to participate the assessment.
Results: Of 71 participants enrolled, 41 responded to the survey, 37 (37/41, 90.24%) of whom were from RNAS+ member countries while the remaining 4 (4/41, 9.76%) were international observers. Most respondents (38/41, 92.68%) are familiar with RNAS+. Respondents reported that China’s contributions were mainly to improve capacity building, and provide funding support, coordination responsibility, and joint application of the cooperation program towards RNAS+ development. The average scores of China’s contributions in the above four fields were 8.92, 8.64, 8.75, and 8.67, respectively, with an overall assessment score of 8.81 (10 maximum score). The challenge of RNAS+ includes the lack of sustainable funding and skills, and most participants indicated their continual need of China’s support.
Conclusions This survey showed that China plays an important role in the development of RNAS+. This network-type organization for disease control and research can yet be regarded as a great potential pattern for China to enhance regional cooperation. These findings can be used to promote future cooperation between China and other RNAS+ member countries.
Figure 1
Figure 2
Figure 3
Figure 4
Loading...